SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024

Rhea-AI Summary

SI-BONE, a company specializing in solutions for musculoskeletal disorders, will present at the Truist Securities 2024 MedTech Conference in Boston on June 18, 2024. Management will hold a fireside chat at 3:40 p.m. ET / 12:40 p.m. PT. Investors can listen to the live webcast by registering through a provided link. The webcast will also be available on the company's website and archived for 90 days post-event.

Positive

• SI-BONE's participation in a well-regarded MedTech conference improves visibility and investor engagement.
• The fireside chat may provide insights into the company's future strategies and performance.
• Archiving the webcast for 90 days allows a broader audience to access the presentation.

Negative

• No new product launches or significant announcements mentioned in the press release.
• immediate business impact as the announcement focuses on an event rather than financial results or clinical data.

SANTA CLARA, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today announced that the company will be participating in the upcoming 2024 Truist Securities MedTech Conference in Boston. Management will be hosting a fireside chat on Tuesday, June 18, at 3:40 p.m. Eastern Time / 12:40 p.m. Pacific Time.

Investors interested in listening to the conference call may do so by registering at this link: https://wsw.com/webcast/truist5/sibn/2067200. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event.

About SI-BONE, Inc.

SI-BONE (NASDAQ: SIBN) is a global leader in technology for surgical treatment of musculoskeletal disorders of the sacropelvic anatomy. Since pioneering minimally invasive surgery of the SI joint in 2009, SI-BONE has supported over 3,700 surgeons in performing a total of more than 100,000 sacropelvic procedures. A unique body of clinical evidence supports the use of SI-BONE’s technologies, including four randomized controlled trials and over 130 peer reviewed publications. SI-BONE has leveraged its leadership in minimally invasive SI joint fusion to commercialize novel solutions for adjacent markets, including adult deformity, spinopelvic fixation, and pelvic trauma.

For additional information on the company or the products including risks and benefits, please visit www.si-bone.com.

iFuse Bedrock Granite, iFuse-TORQ, SI-BONE and iFuse INTRA are registered trademarks of SI-BONE, Inc. ©2024 SI-BONE, Inc. All Rights Reserved.

Investor Contact: Saqib Iqbal investors@si-bone.com

FAQ

What is the date of SI-BONE's presentation at the Truist Securities 2024 MedTech Conference?

SI-BONE will present on June 18, 2024.

At what time is SI-BONE's fireside chat scheduled during the 2024 MedTech Conference?

The fireside chat is scheduled for 3:40 p.m. Eastern Time / 12:40 p.m. Pacific Time.

How can investors listen to SI-BONE's presentation at the MedTech Conference?

Investors can listen by registering through the provided link.

Will the webcast of SI-BONE's presentation be available after the live event?

Yes, it will be archived and available for replay for at least 90 days.